Kramann Lab

University Hospital Aachen

Nordrhein-Westfalen (DEA) · Germany

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Consolidator Grant · 2021

Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease

Chronic Kidney Disease (CKD) represents an important medical, social and economic burden with high morbidity and mortality. The prevalence of CKD has reached >10% in the developed world, and CKD globally accounts for more years lived with disability than all neoplasms combined. Therapeutic strategies to treat CKD or tools for risk stratification of patients are limited and the field has produced the fewest translational randomized clinical trials in medicine while diagnosis is still based on invasive tissue biopsies. TargetCKD aims to establish a holistic understanding of cellular and molecular mechanisms that drive disease to develop novel diagnostic, predictive and therapeutic options.…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at University Hospital Aachen